BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1609413)

  • 1. Induction of mucopolysaccharidosis in rats by treatment with immunostimulatory acridine derivatives.
    Grave S; Lüllmann H; Lüllmann-Rauch R; Osterkamp G; Prokopek M
    Toxicol Appl Pharmacol; 1992 Jun; 114(2):215-24. PubMed ID: 1609413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal storage of sulfated glycosaminoglycans in cultured fibroblasts exposed to immunostimulatory acridine derivatives.
    Handrock K; Laschke A; Lüllmann-Rauch R; Vogt RD; Ziegenhagen M
    Toxicol Appl Pharmacol; 1992 Jun; 114(2):204-14. PubMed ID: 1609412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced intralysosomal storage of sulfated glycosaminoglycans (GAGs): a methodical pitfall occurring with acridine derivatives.
    Lüllmann-Rauch R
    Exp Toxicol Pathol; 1994 Oct; 46(4-5):315-22. PubMed ID: 7894242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acridine Orange, a precipitant for sulfated glycosaminoglycans, causes mucopolysaccharidosis in cultured fibroblasts.
    Lüllmann-Rauch R; Ziegenhagen M
    Histochemistry; 1991; 95(3):263-8. PubMed ID: 1904847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucopolysaccharidosis (MPS) in ocular tissues as induced by amphiphilic di-cationic drugs.
    Lüllmann-Rauch R
    Lens Eye Toxic Res; 1990; 7(3-4):263-79. PubMed ID: 2129218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tilorone-induced mucopolysaccharidosis in rats. Biochemical investigations.
    Prokopek M
    Biochem Pharmacol; 1991 Nov; 42(11):2187-91. PubMed ID: 1720315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and functional changes due to drug-induced lysosomal storage of sulphated glycosaminoglycans in the rat retina.
    Bredehorn T; Clausen M; Duncker G; Lüllmann-Rauch R
    Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):788-93. PubMed ID: 11760042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimalarials quinacrine and chloroquine induce weak lysosomal storage of sulphated glycosaminoglycans in cell culture and in vivo.
    Lüllmann-Rauch R; Pods R; von Witzendorff B
    Toxicology; 1996 Jun; 110(1-3):27-37. PubMed ID: 8658557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal glycosaminoglycan storage as induced by dicationic amphiphilic drugs: investigation into the mechanisms underlying the slow reversibility.
    Bispinck F; Fischer J; Lüllmann-Rauch R; von Witzendorff B
    Toxicology; 1998 Jul; 128(2):91-100. PubMed ID: 9710150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucopolysaccharidosis and lipidosis in rats treated with tilorone analogues.
    Hein L; Lüllmann-Rauch R
    Toxicology; 1989 Oct; 58(2):145-54. PubMed ID: 2508267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental mucopolysaccharidosis: preservation and ultrastructural visualization of intralysosomal glycosaminoglycans by use of the cationic dyes cuprolinic blue and toluidine blue.
    Lüllmann-Rauch R
    Histochemistry; 1989; 93(2):149-54. PubMed ID: 2515171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced glycosaminoglycan storage: dose-dependent changes in the pattern of accumulated glycosaminoglycans in cultured bovine and human fibroblasts.
    Fischer J
    Biochem Pharmacol; 1996 Nov; 52(9):1331-7. PubMed ID: 8937442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tilorone-induced lysosomal lesions: the bisbasic character of the drug is essential for its high potency to cause storage of sulphated glycosaminoglycans.
    Fischer J; Hein L; Lüllmann-Rauch R; von Witzendorff B
    Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):369-75. PubMed ID: 8615802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced lysosomal storage of sulphated glycosaminoglycans.
    Fischer J; Lüllmann H; Lüllmann-Rauch R
    Gen Pharmacol; 1996 Dec; 27(8):1317-24. PubMed ID: 9304401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced lysosomal storage of sulfated glycosaminoglycans. Studies on the underlying structure-activity relationships.
    Handrock K; Lüllmann-Rauch R; Vogt RD
    Toxicology; 1993 Dec; 85(2-3):199-213. PubMed ID: 8303713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultured corneal fibroblasts as a model system for the demonstration of drug-induced mucopolysaccharidosis.
    Burmester J; Handrock K; Lüllmann-Rauch R
    Arch Toxicol; 1990; 64(4):291-8. PubMed ID: 2117432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucopolysaccharidosis-like cellular alterations in chondrocytes of rats treated with tilorone.
    Lüllmann-Rauch R; Michel G; Peters A
    Exp Mol Pathol; 1988 Oct; 49(2):279-89. PubMed ID: 3139444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal storage of sulphated glycosaminoglycans induced by dicationic amphiphilic drug molecules: significance of the central planar ring system.
    Lüllmann-Rauch R; von Witzendorff B
    Pharmacol Toxicol; 1996 Sep; 79(3):109-13. PubMed ID: 8884867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal storage of sulfated glycosaminoglycans induced by two bis-aminomethyl anthrachinones.
    Fischer J; Lüllmann-Rauch R; Stubbe E; von Witzendorff B
    Arch Toxicol; 1996; 70(6):373-9. PubMed ID: 8975637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tilorone-induced lysosomal storage mimicking the features of mucopolysaccharidosis and of lipidosis in rat liver.
    Lüllmann-Rauch R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 44(3):355-68. PubMed ID: 6198800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.